Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Early detection of cancer therapeutics-related cardiac dysfunction].
Potier A, Ederhy S, Ancedy Y, Etienney A, Soulat-Dufour L, Chauvet M, Hollebecque A, Adavane-Scheuble S, Boccara F, Soria JC, Cohen A. Potier A, et al. Among authors: hollebecque a. Bull Cancer. 2016 Jul-Aug;103(7-8):667-73. doi: 10.1016/j.bulcan.2016.05.004. Epub 2016 Jul 12. Bull Cancer. 2016. PMID: 27417336 Review. French.
Bevacizumab-induced laryngeal necrosis.
Hartl DM, Bahleda R, Hollebecque A, Bosq J, Massard C, Soria JC. Hartl DM, et al. Among authors: hollebecque a. Ann Oncol. 2012 Jan;23(1):276-278. doi: 10.1093/annonc/mdr515. Epub 2011 Nov 4. Ann Oncol. 2012. PMID: 22056850 Free article. No abstract available.
Evaluation of sexuality, health-related quality-of-life and depression in advanced cancer patients: a prospective study in a Phase I clinical trial unit of predominantly targeted anticancer drugs.
Rouanne M, Massard C, Hollebecque A, Rousseau V, Varga A, Gazzah A, Neuzillet Y, Lebret T, Soria JC. Rouanne M, et al. Among authors: hollebecque a. Eur J Cancer. 2013 Jan;49(2):431-8. doi: 10.1016/j.ejca.2012.08.008. Epub 2012 Sep 6. Eur J Cancer. 2013. PMID: 22959468 Clinical Trial.
Targeted therapy-induced radiation recall.
Levy A, Hollebecque A, Bourgier C, Loriot Y, Guigay J, Robert C, Delaloge S, Bahleda R, Massard C, Soria JC, Deutsch E. Levy A, et al. Among authors: hollebecque a. Eur J Cancer. 2013 May;49(7):1662-8. doi: 10.1016/j.ejca.2012.12.009. Epub 2013 Jan 8. Eur J Cancer. 2013. PMID: 23312391
Pharmacokinetic/pharmacodynamic modelling-based optimisation of administration schedule for the histone deacetylase inhibitor abexinostat (S78454/PCI-24781) in phase I.
Fouliard S, Robert R, Jacquet-Bescond A, du Rieu QC, Balasubramanian S, Loury D, Loriot Y, Hollebecque A, Kloos I, Soria JC, Chenel M, Depil S. Fouliard S, et al. Among authors: hollebecque a. Eur J Cancer. 2013 Sep;49(13):2791-7. doi: 10.1016/j.ejca.2013.05.009. Epub 2013 Jun 18. Eur J Cancer. 2013. PMID: 23790467 Clinical Trial.
Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors.
Gandhi L, Bahleda R, Tolaney SM, Kwak EL, Cleary JM, Pandya SS, Hollebecque A, Abbas R, Ananthakrishnan R, Berkenblit A, Krygowski M, Liang Y, Turnbull KW, Shapiro GI, Soria JC. Gandhi L, et al. Among authors: hollebecque a. J Clin Oncol. 2014 Jan 10;32(2):68-75. doi: 10.1200/JCO.2012.47.2787. Epub 2013 Dec 9. J Clin Oncol. 2014. PMID: 24323026 Clinical Trial.
Dysphonia induced by anti-angiogenic compounds.
Saavedra E, Hollebecque A, Soria JC, Hartl DM. Saavedra E, et al. Among authors: hollebecque a. Invest New Drugs. 2014 Aug;32(4):774-82. doi: 10.1007/s10637-013-0049-2. Epub 2013 Dec 18. Invest New Drugs. 2014. PMID: 24343672 Review.
241 results